SI-BONE, Inc. (SIBN) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
SIBN Revenue Growth
Revenue Breakdown
SIBN's revenue distribution by segment and geography
By Geography
SIBN Revenue Analysis (2014–2025)
As of May 8, 2026, SI-BONE, Inc. (SIBN) generated trailing twelve-month (TTM) revenue of $200.9 million, reflecting strong growth of +15.0% year-over-year. The most recent quarter (Q4 2025) recorded $56.4 million in revenue, up 15.8% sequentially.
Looking at the longer-term picture, SIBN's 5-year compound annual growth rate (CAGR) stands at +22.3%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $200.9 million in 2025, representing a new all-time high.
When compared to Healthcare sector peers including XTNT (+16.9% YoY), ATEC (-7.4% YoY), and NVAX (-52.5% YoY), SIBN has underperformed the peer group in terms of revenue growth. Compare SIBN vs XTNT →
SIBN Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SIBNCurrent | $201M | +15.0% | +22.3% | -11.1% | |
 XTNT | $117M | +16.9% | +12.6% | -10.3% | |
 ATEC | $764M | -7.4% | +39.5% | -10.7% | |
 NVAX | $1.1B | -52.5% | +118.8% | 50.1% | |
 GMED | $2.9B | +23.5% | +30.1% | 16.3% | |
 OSIS | $1.7B | +7.0% | +8.0% | 12.7% |
SIBN Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $200.9M | +20.2% | $159.9M | 79.6% | $-22,330,000 | -11.1% |
| 2024 | $167.2M | +20.4% | $132.1M | 79.0% | $-35,248,000 | -21.1% |
| 2023 | $138.9M | +30.5% | $109.4M | 78.8% | $-46,931,000 | -33.8% |
| 2022 | $106.4M | +18.0% | $90.7M | 85.2% | $-59,609,000 | -56.0% |
| 2021 | $90.2M | +22.8% | $79.7M | 88.4% | $-51,670,000 | -57.3% |
| 2020 | $73.4M | +9.0% | $64.5M | 87.9% | $-38,567,000 | -52.6% |
| 2019 | $67.3M | +21.5% | $60.5M | 89.9% | $-36,003,000 | -53.5% |
| 2018 | $55.4M | +15.4% | $50.5M | 91.3% | $-11,965,000 | -21.6% |
| 2017 | $48.0M | +14.0% | $42.9M | 89.3% | $-17,350,000 | -36.2% |
| 2016 | $42.1M | +2.3% | $36.9M | 87.7% | $-17,565,000 | -41.7% |
See SIBN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SIBN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SIBN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSIBN — Frequently Asked Questions
Quick answers to the most common questions about buying SIBN stock.
Is SIBN's revenue growth accelerating or slowing?
SIBN maintains +15.0% revenue growth, in line with its 5-year CAGR of +22.3%. TTM revenue stands at $201M. Growth rate remains consistent with historical average.
What is SIBN's long-term revenue growth rate?
SI-BONE, Inc.'s 5-year revenue CAGR of +22.3% reflects the sustained expansion pattern. Current YoY growth of +15.0% is near this long-term average.
How is SIBN's revenue distributed by segment?
SIBN reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.